PLASMA PROTEIN THERAPEUTICS ASSOCIATION for PLASMA PROTEIN THERAPEUTICS ASSOCIATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Medicare reimbursement relating to plasma protein therapies; Federal Medicaid and Federal drug pricing programs; FDA drug safety legislation; and follow-on biologics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE BIRKOFER New | — |
| JOHN EDWARD GREISSING New | Legal Fellow and Counsel, Senate Committee on Judiciary |
| JONATHAN MCKNIGHT MCKNIGHT New | — |
Medicare/Medicaid MMM
Medicare reimbursement relating to plasma protein therapies; Federal Medicaid and Federal drug pricing programs; FDA drug safety legislation; and follow-on biologics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE BIRKOFER New | — |
| JOHN EDWARD GREISSING New | Legal Fellow and Counsel, Senate Committee on Judiciary |
| JONATHAN MCKNIGHT MCKNIGHT New | — |
Pharmacy PHA
Medicare reimbursement relating to plasma protein therapies; Federal Medicaid and Federal drug pricing programs; FDA drug safety legislation; and follow-on biologics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE BIRKOFER New | — |
| JOHN EDWARD GREISSING New | Legal Fellow and Counsel, Senate Committee on Judiciary |
| JONATHAN MCKNIGHT MCKNIGHT New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| GRIFOLS, S.A. | Spain | Spain | 100.0% | $33,000 |
| OCTAPHARMA AG | Switzerland | Switzerland | 100.0% | $33,000 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.